QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-rockwell-medical-lowers-price-target-to-25

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...

 rockwell-medical-affirms-fy2025-sales-guidance-of-65000m-70000m-vs-68374m-est

Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 mil...

 rockwell-medical-q3-sales-15927m-miss-16241m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly sales of $15.927 million which missed the analyst consensus estimate of $16.2...

 rockwell-medical-affirms-fy2025-sales-guidance-of-65000m-70000m-vs-68229m-est

Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 mil...

 rockwell-medical-q2-adj-eps-001-beats-005-estimate-sales-16071m-miss-16332m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0....

 rockwell-medical-affirms-fy2025-sales-guidance-of-6500m-7000m-vs-6742m-est

GUIDANCERockwell confirms its 2025 annual guidance as follows: 2025 Annual GuidanceNet Sales$65.0M to $70.0MGross Margin16% to ...

 hc-wainwright--co-maintains-buy-on-rockwell-medical-lowers-price-target-to-3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION